Welcome to our dedicated page for NATURAL HEALTH TRENDS SEC filings (Ticker: NHTC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Natural Health Trends Corp. filings document the regulatory record for a Nasdaq-listed operating company with common stock trading under NHTC. Form 8-K reports record quarterly and annual operating results, dividend-related announcements, restructuring effects and material capital actions, including a completed repurchase of common stock from a large holder under the company’s authorized repurchase program.
Proxy statements cover board and shareholder voting matters, executive and director compensation, equity-award valuation and governance disclosures. The filings also describe the company’s security registration, capital structure, financial condition and material agreements associated with its direct-selling and e-commerce business under the NHT Global brand.
Natural Health Trends Corp., an international direct-selling and e-commerce company, reported weaker results for the quarter ended June 30, 2026. Net sales were $7.6 million, down $2.2 million or 23% year over year, and six‑month sales fell 18% to $16.8 million. Hong Kong, with products largely delivered into China, contributed 82.8% of Q2 net sales, and sales there declined amid tariff-related economic uncertainty, regulatory concerns in China and disruptions from certain independent member activities.
Gross margin improved to 75.2% as production shifted from the U.S. to East Asia, but the company still posted a Q2 net loss of $451 thousand and a six‑month net loss of $605 thousand versus small profits a year earlier. Operating cash flow used was $2.2 million in the first half, partly offset by $12.4 million provided by investing activities. The balance sheet shows $18.6 million of cash, cash equivalents and marketable securities, working capital of $11.8 million and a 2.0:1 current ratio. In February 2026, the company repurchased 2,935,227 shares (about 25.5% of outstanding) at $2.00 per share and paid $0.10 per share in cash dividends in each of the first two quarters, while warning of ongoing risks from Chinese regulatory changes, Hong Kong’s evolving environment and potential tariff shifts.
Natural Health Trends Corp. reported weaker results for the quarter ended June 30, 2026. Net sales were $7,603 thousand, down from $9,813 thousand a year earlier, leading to a net loss of $451 thousand versus net income of $15 thousand in the prior-year quarter. For the first six months of 2026, net sales were $16,809 thousand and the company recorded a net loss of $605 thousand, compared with net income of $137 thousand in the first half of 2025.
Total cash, cash equivalents and marketable securities were $18.6 million at June 30, 2026, down from $28.9 million at December 31, 2025, largely due to share repurchases and dividends. Operating activities used $2,161 thousand of cash in the first half. The Board authorized resuming stock repurchases, with $15.9 million remaining under the program. Management cited a challenging environment in China, regulatory uncertainty, and member conduct issues that disrupted business, while highlighting restructuring savings of about $300,000 in the quarter and over $600,000 year-to-date.
NATURAL HEALTH TRENDS CORP filed an initial Form 3 for director Ellen Sun. The filing lists no insider transactions, with zero shares reported as bought, sold, or exercised and no derivative positions disclosed. This is a routine disclosure establishing Sun’s status as a reporting insider.
Natural Health Trends Corp. held its 2026 annual meeting, where stockholders approved the 2026 Equity Incentive Plan authorizing up to 1,100,000 shares of common stock for equity awards to employees, directors, and other service providers.
Stockholders also elected Randall A. Mason, Chris T. Sharng, Ellen Sun, and Ching C. Wong as directors by plurality vote. They ratified CBIZ CPAs P.C. as independent registered public accounting firm for the fiscal year ending December 31, 2026. The meeting had 8,577,848 shares entitled to vote, with 4,982,843 shares, or 58.1%, represented in person or by proxy.
Natural Health Trends Corp. reported weaker results for the quarter ended March 31, 2026. Net sales were $9.2 million, down 14% from $10.7 million a year earlier, mainly from lower Hong Kong sales tied to China demand. Gross margin improved to 75.0% from 73.6% as more production shifted from the U.S. to East Asia.
The company posted a net loss of $0.2 million versus net income of $0.1 million in the prior-year quarter, with diluted EPS moving from $0.01 to $(0.02). Selling, general and administrative expenses fell in dollars but rose as a percentage of sales due to the revenue decline.
Liquidity remains solid: cash, cash equivalents and marketable securities totaled $21.2 million, and working capital was $13.3 million with a 2.0-to-1 current ratio. During the quarter, the company repurchased 2.94 million shares (about 25.5% of outstanding) for roughly $5.9 million and paid a $0.10 per-share dividend, while active members decreased to 26,400 from 30,180 a year earlier.
Natural Health Trends Corp. reported first quarter 2026 net sales of $9.2 million, down from $10.7 million a year earlier, and a net loss of $154,000 compared with net income of $122,000. Diluted earnings per share were a loss of $0.02 versus earnings of $0.01 in the prior-year quarter.
Cash, cash equivalents and restricted cash increased to $9.2 million at March 31, 2026, from $6.8 million at the start of the year, helped by net cash provided by investing activities. The company repurchased $5.9 million of common stock, paid $858,000 in dividends, and declared a quarterly cash dividend of $0.10 per share. Management highlighted stable orders in Hong Kong and China, approximately $300,000 of cost savings from a restructuring program, and ongoing investment in new products and technology.
Natural Health Trends Corp. has called its 2026 annual stockholder meeting for May 7, 2026 in Hong Kong. Stockholders will vote on electing four directors, approving a new 2026 Equity Incentive Plan, and ratifying CBIZ CPAs P.C. as the independent auditor for 2026.
The proposed 2026 Equity Incentive Plan would authorize 1,100,000 shares for equity awards, which the company states is about 12.8% dilution as of March 19, 2026 and fewer shares than under its expiring 2016 plan. The proxy also details board independence, committee structure, executive and director compensation, phantom equity awards, and pay-versus-performance data showing 2025 net loss of $882,000 and a total shareholder return value of $151.21 on an initial $100 investment.
Natural Health Trends Corp. is asking stockholders to vote at its May 7, 2026 annual meeting in Hong Kong on electing four directors, approving a new 2026 Equity Incentive Plan, and ratifying CBIZ CPAs P.C. as auditor for 2026.
The proposed equity plan would authorize 1,100,000 shares for awards, which the company estimates as approximately 12.8% dilution as of March 19, 2026. This replaces the 2016 plan, under which 1,129,047 shares remained available as of December 31, 2025. The board highlights a three-year average burn rate of 0.0028%, well below the 1.57% ISS industry cap.
The proxy details governance and compensation practices, including phantom equity awards for executives and directors, double-trigger change-in-control severance, and a prohibition on hedging by insiders. For 2025, the president’s total compensation was $1,187,357 and the CFO’s was $480,474, while the company reported net loss of $882 thousand and year-end total shareholder return of 151.21 on a $100 base investment.
Natural Health Trends Corp. (NHTC) files its annual report describing an international direct-selling and e-commerce business focused on “NHT Global” wellness, herbal, beauty, lifestyle and at-home test products. The company operates across the Americas, Greater China, Southeast Asia, South Korea, Japan, India, Europe, Russia and Kazakhstan.
At February 17, 2026, common shares outstanding were 8,577,848. Hong Kong remains critical, generating about 82% of 2025 revenue, with most sales ultimately delivered to members in China. Active members fell from 30,870 to 26,650 year over year, driven largely by declines in Hong Kong and Russia/Kazakhstan.
In 2025 the company relocated its headquarters from Hong Kong to California and implemented a restructuring plan, including workforce optimization, shifting some manufacturing to Asia and office downsizing. Management expects about $1.5 million in annualized cost savings, with most benefits in 2026 and the rest thereafter.
The report highlights several risks: persistent negative operating cash flows in each of the four years ended December 31, 2025; heavy dependence on a few products and single-source suppliers; intense competition in direct selling; and significant regulatory, political, data-privacy and trade risks tied to operations in China and Hong Kong, where evolving direct-selling, data and cyber-security laws and U.S.–China trade tensions could materially affect sales and profitability.